Lasa Supergenerics Limited

NSE LASA.NS

Lasa Supergenerics Limited Free Cash Flow for the year ending March 31, 2024: USD 256.41 K

Lasa Supergenerics Limited Free Cash Flow is USD 256.41 K for the year ending March 31, 2024, a 112.18% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Lasa Supergenerics Limited Free Cash Flow for the year ending March 31, 2023 was USD -2.10 M, a -252.37% change year over year.
Lasa Supergenerics Limited Free Cash Flow for the year ending March 31, 2022 was USD 1.38 M, a -70.87% change year over year.
Lasa Supergenerics Limited Free Cash Flow for the year ending March 31, 2021 was USD 4.74 M, a 174.99% change year over year.
Lasa Supergenerics Limited Free Cash Flow for the year ending March 31, 2020 was USD 1.72 M, a -59.14% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

NSE: LASA.NS

Lasa Supergenerics Limited

CEO	Dr. Omkar Pravin Herlekar
IPO Date	Sept. 21, 2017
Location	India
Headquarters	No. 506 & 507, Midas Sahar Plaza
Employees	77
Sector	Consumers Staples
Industries Pet Food Agriculture Biotechnology Cleaning Supplies Cosmetics Dairy & Milk Personal Care Pharmaceuticals

Description

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers veterinary and other API products, anthelmintic products, animal feed ingredients, and reagents for therapeutic use. The company also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Mumbai, India.

Key trends

Past 5 years